Medicine Administration Device With Pre-Delivery Drug Authentication

The patent introduces an authentication system as an intermediary between the medicine container and the delivery mechanism. This system verifies medicine authenticity through database checks of identifiers (barcodes, RFID tags, etc.) before allowing administration, thereby ensuring medicine safety without requiring complex modifications to the core delivery function. The authentication module acts as a separate verification layer that maintains reliability while preserving operational simplicity.

The authentication process is performed preliminarily, before the medicine delivery operation. By verifying medicine authenticity, checking expiration dates, and validating storage conditions in advance, the system ensures that only authenticated medicines are administered. This preliminary verification approach prevents unsafe medicine delivery while keeping the delivery mechanism itself simple and efficient.

The system implements a tiered authentication approach where essential parameters (medicine identifier, expiration date) are verified as minimum requirements, while additional parameters (storage temperature history, manufacturer verification) can be checked optionally or in subsequent validation stages. This partial verification strategy ensures authentication accuracy for critical safety parameters while minimizing processing time by not requiring exhaustive verification of all possible parameters in every case.

The authentication process is segmented into multiple independent verification steps: identifier validation, expiration check, storage condition verification, and manufacturer authentication. Each segment can be processed separately and in parallel where possible, allowing the system to verify multiple parameters accurately while managing processing time through modular, organized validation sequences.

The authentication requirement is implemented dynamically rather than statically. Under normal circumstances, authentication is mandatory to prevent counterfeit drug administration. However, the system incorporates emergency bypass mechanisms that allow operators to override authentication requirements in life-threatening situations where immediate medicine delivery is critical. This dynamic approach maintains strong counterfeit prevention while preserving ease of operation during emergencies.

The system prepares for potential authentication failures or emergency situations in advance by incorporating bypass options and alert mechanisms. When authentication fails or an emergency arises, pre-programmed protocols allow for alternative action paths, ensuring that the system can respond appropriately without requiring complex real-time decision-making. This beforehand cushioning maintains safety through mandatory authentication while ensuring operational ease during emergencies through pre-planned override procedures.